Exclusive

Exclusive By Rachel Cohrs

House Democrats slip drug pricing proposal into Covid-19 relief bill

Exclusive By Nicholas Florko

Trump officials actively lobbied to deny states money for vaccine rollout last fall 

Exclusive By Olivia Goldhill

Undercounting of Covid-19 deaths is greatest in pro-Trump areas, analysis shows

Exclusive By Rachel Cohrs

PhRMA sues to block Trump administration 340B rule

Exclusive By Nicholas Florko

In a last-minute, intra-agency scuffle, HHS overrules FDA pick for a key position 

Exclusive By Matthew Herper

Tempus unveils prototype cube that talks back to oncologists

Exclusive By Olivia Goldhill

Pfizer decision to turn off temperature sensors forced scramble to ensure Covid-19 vaccines kept ultra-cold

Exclusive By Nicholas Florko

BIO files lawsuit to block Trump international drug pricing policy

Exclusive By Erin Brodwin

CommonHealth, the Android answer to Apple Health Records, expands to 230 health systems

Exclusive By Lev Facher

White House to host Covid-19 vaccine summit, as Trump seeks to burnish record

Exclusive By Helen Branswell

Divisions emerge among U.S. officials over when first Covid-19 vaccine doses will be available — and for whom

Exclusive By Matthew Herper and Damian Garde

Raging at the pandemic, a VC raises $800M for a company that aims to transform biotech manufacturing

Exclusive By Ed Silverman

STAT-Harris Poll: Most Americans won’t get a Covid-19 vaccine unless it cuts risk by half

Exclusive By Ed Silverman

STAT-Harris Poll: The share of Americans interested in getting Covid-19 vaccine as soon as possible is dropping

Special Report By Lev Facher

First-of-its-kind examination shows how widely pharma showers campaign cash at the state level

Exclusive By Damian Garde and Adam Feuerstein

Selling stock like clockwork, Moderna’s top doctor gets $1 million richer every week

Exclusive By Alison Insinger

Top health official echoes Trump’s Covid-19 views, drawing accusations of politicizing U.S. mental health agency

Exclusive By Rebecca Robbins, Adam Feuerstein, and Helen Branswell

AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.

Exclusive By Nicholas Florko and Lev Facher

PhRMA scrambles to respond to Trump’s drug pricing ultimatum, as Monday deadline looms

Exclusive By Helen Branswell, Kate Sheridan, Casey Ross, and Andrew Joseph

The Trump administration haphazardly gave away millions of Covid-19 masks — to schools, broadcasters, and large corporations

Exclusive By Nicholas Florko

FDA’s reopening plan will keep biologics labs shuttered far longer than other government labs

Special Report By Lev Facher

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Exclusive By Erin Brodwin

Eyeing an IPO, Hims expands further into virtual mental health care

Exclusive By Nicholas Florko

In unusual arrangement, deputy HHS secretary’s wife has been lobbying the agency on behalf of health care companies

Exclusive By Matthew Herper and Erin Riglin

Data show panic and disorganization dominate the study of Covid-19 drugs